| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 3/6 |
| Past Performance | 1/6 |
| Financial Health | 3/6 |
| Dividends | 2/6 |
Rewards
Risk Analysis
+ 1 more risk
Viatris Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$10.84 |
| 52 Week High | US$12.52 |
| 52 Week Low | US$8.19 |
| Beta | 1.15 |
| 1 Month Change | -0.94% |
| 3 Month Change | -0.083% |
| 1 Year Change | 31.78% |
| 3 Year Change | -2.70% |
| 5 Year Change | n/a |
| Change since IPO | -22.05% |
Recent News & Updates
Recent updates
Shareholder Returns
| VTRS | AT Pharmaceuticals | AT Market | |
|---|---|---|---|
| 7D | 2.4% | 1.9% | -0.08% |
| 1Y | 31.8% | 8.7% | 2.6% |
Return vs Industry: VTRS exceeded the Austrian Pharmaceuticals industry which returned 8.7% over the past year.
Return vs Market: VTRS exceeded the Austrian Market which returned 2.6% over the past year.
Price Volatility
| VTRS volatility | |
|---|---|
| VTRS Average Weekly Movement | 4.0% |
| Pharmaceuticals Industry Average Movement | 4.9% |
| Market Average Movement | 3.4% |
| 10% most volatile stocks in AT Market | 5.2% |
| 10% least volatile stocks in AT Market | 1.7% |
Stable Share Price: VTRS has not had significant price volatility in the past 3 months.
Volatility Over Time: VTRS's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1961 | 38,000 | Scott Smith | www.viatris.com |
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs).
Viatris Inc. Fundamentals Summary
| VTRS fundamental statistics | |
|---|---|
| Market cap | €12.84b |
| Earnings (TTM) | €51.13m |
| Revenue (TTM) | €14.42b |
251.2x
P/E Ratio0.9x
P/S RatioIs VTRS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| VTRS income statement (TTM) | |
|---|---|
| Revenue | US$15.43b |
| Cost of Revenue | US$8.69b |
| Gross Profit | US$6.73b |
| Other Expenses | US$6.68b |
| Earnings | US$54.70m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 09, 2024
| Earnings per share (EPS) | 0.046 |
| Gross Margin | 43.64% |
| Net Profit Margin | 0.35% |
| Debt/Equity Ratio | 88.5% |
How did VTRS perform over the long term?
See historical performance and comparison